Trials / Completed
CompletedNCT00255476
The IRESSA Novel Head and Neck Chemotherapy Evaluation Study
A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU, as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the objectie tumour response rate between the cisplatin/5FU and cisplatin/5FU plus ZD1839 combination
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gefitinib | |
| DRUG | cisplatin | |
| DRUG | 5-flourouracil |
Timeline
- Start date
- 2004-02-01
- Completion
- 2007-07-01
- First posted
- 2005-11-21
- Last updated
- 2009-04-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00255476. Inclusion in this directory is not an endorsement.